Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Phloretin Protects Macrophages from E. coli-Induced Inflammation through the TLR4 Signaling Pathway

  • Chauhan, Anil Kumar (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Jang, Mihee (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Kim, Yangmee (Department of Bioscience and Biotechnology, Konkuk University)
  • Received : 2019.10.28
  • Accepted : 2019.12.24
  • Published : 2020.03.28
Download PDF
⟨ Previous Next ⟩

Abstract

Macrophages are the cells of the first-line defense system, which protect the body from foreign invaders such as bacteria. However, Gram-negative bacteria have always been the major challenge for macrophages due to the presence of lipopolysaccharides on their outer cell membrane. In the present study, we evaluated the effect of phloretin, a flavonoid commonly found in apple, on the protection of macrophages from Escherichia coli infection. RAW 264.7 cells infected with standard E. coli, or virulent E. coli K1 strain were treated with phloretin in a dose-dependent manner to examine its efficacy in protection of macrophages. Our results revealed that phloretin treatment reduced the production of nitric oxide (NO) and generation of reactive oxygen species along with reducing the secretion of proinflammatory cytokines induced by the E. coli and E. coli K1 strains in a concentration-dependent manner. Additionally, treatment of phloretin downregulated the expression of E. coli-induced major inflammatory markers i.e. cyclooxygenase-2 (COX-2) and hemeoxygenase-1 (HO-1), in a concentration dependent manner. Moreover, the TLR4-mediated NF-κB pathway was activated in E. coli-infected macrophages but was potentially downregulated by phloretin at the transcriptional and translational levels. Collectively, our data suggest that phloretin treatment protects macrophages from infection of virulent E. coli K1 strain by downregulating the TLR4-mediated signaling pathway and inhibiting NO and cytokine production, eventually protecting macrophages from E. coli-induced inflammation.

Keywords

References

  1. Nathan C. 2002. Points of control in inflammation. Nature 420: 846-852. https://doi.org/10.1038/nature01320
  2. Gabay C. 2006. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8: 1-6. https://doi.org/10.1186/ar1917
  3. Tasneem S, Liu B, Li B, Choudhary MI, Wang W. 2019. Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacol. Res. 139: 126-140. https://doi.org/10.1016/j.phrs.2018.11.001
  4. Mankhong S, Iawsipo P, Srisook E, Srisook K. 2019. 4-Methoxycinnamyl p-coumarate isolated from Etlingera pavieana rhizomes inhibits inflammatory response via suppression of NF-${\kappa}B$, Akt and AP-1 signaling in LPS-stimulated RAW 264.7 macrophages. Phytomedicine 54: 89-97. https://doi.org/10.1016/j.phymed.2018.09.193
  5. Hirayama D, Iida T, Nakase H. 2017. The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis. Int. J. Mol. Sci. 19: pii: E92.
  6. Petersen HJ, Smith AM. 2013. The role of the innate immune system in granulomatous disorders. Front. Immunol. 4: 120. https://doi.org/10.3389/fimmu.2013.00120
  7. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. 1996. Studies on immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 50: 69-76. https://doi.org/10.1016/0378-8741(95)01318-0
  8. Mariadoss AVA, Vinyagam R1, Rajamanickam V, Sankaran V, Venkatesan S, David E. 2019. Pharmacological aspects and potential use of phloretin: A systemic review. Mini. Rev. Med. Chem. 19: 1060-1067. https://doi.org/10.2174/1389557519666190311154425
  9. Tsao R, Yang R, Young JC, Zhu H. 2003. Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography (HPLC). J. Agric. Food Chem. 51: 6347-6353. https://doi.org/10.1021/jf0346298
  10. Wei Y, Zhang J, Memon AH, Liang H. 2017. Molecular model and in vitro antioxidant activity of a water-soluble and stable phloretin/hydroxypropyl-${\beta}$-cyclodextrin inclusion complex. J. Mol. Liq. 236: 68-75. https://doi.org/10.1016/j.molliq.2017.03.098
  11. Huang WC, Dai YW, Peng HL, Kang CW, Kuo CY, Liou CJ. 2015. Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-${\kappa}B$ pathway in the TNF-${\alpha}$-induced HaCaT human keratinocytes. Int. Immunopharmacol. 27: 32-37. https://doi.org/10.1016/j.intimp.2015.04.024
  12. Stangl V, Lorenz M, Ludwig A, Grimbo N, Guether C, Sanad W, et al. 2005. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr. 135: 172-178. https://doi.org/10.1093/jn/135.2.172
  13. Xu M, Gu W, Shen Z, Wang F. 2018. Anticancer activity of phloretin against human gastric cancer cell lines involves apoptosis, cell cycle arrest, and inhibition of cell invasion and JNK signalling pathway. Med. Sci. Monit. 4: 6551-6558.
  14. Barreca D, Bellocco E, Lagana G, Ginestra G, Bisignano C. 2014. Biochemical and antimicrobial activity of phloretin and its glycosilated derivatives present in apple and kumquat. Food Chem. 160: 292-297. https://doi.org/10.1016/j.foodchem.2014.03.118
  15. Cheon D, Kim J, Jeon D, Shin HC, Kim Y. 2019. Target proteins of phloretin for its anti-inflammatory and antibacterial activities against propionibacterium acnes-induced skin infection. Molecules 24: 1319. https://doi.org/10.3390/molecules24071319
  16. Kim J, Durai P, Jeon D, Jung I, Lee S, Park YM, et al. 2018. Phloretin as a potent natural TLR2/1 inhibitor suppresses TLR2-induced inflammation. Nutrients 10: 868. doi:10.3390/nu10070868
  17. Lee JY, Jeong KW, Shin S, Lee JU, Kim Y. 2009. Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors. Bioorg. Med. Chem. 17: 5408-5413. https://doi.org/10.1016/j.bmc.2009.06.059
  18. Jeon D, Jeong MC, Jnawali H, Kwak C, Ryoo S, Jung I, et al. 2017. Phloretin exerts anti-tuberculosis activity and suppresses lung inflammation. Molecules 22: 183. https://doi.org/10.3390/molecules22010183
  19. Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, et al. 2011. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 79: 4819-4827. https://doi.org/10.1128/IAI.05580-11
  20. Jung M, Triebel S, Anke T, Richling E, Erkel G. 2009. Influence of apple polyphenols on inflammatory gene expression. Mol. Nutr. Food Res. 53: 1263-1280. https://doi.org/10.1002/mnfr.200800575
  21. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob. Agents Chemother. 48: 1503-1508. https://doi.org/10.1128/AAC.48.5.1503-1508.2004
  22. Bateman SL, Seed P. 2012. Intracellular Macrophage Infections with E. coli under Nitrosative Stress. Bio Protoc. 2: 20.
  23. Rallabhandi P, Awomoyi A, Thomas KE, Phalipon A, Fujimoto Y, Fukase K, et al. 2008. Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling. J. Immunol. 180: 1139-1147. https://doi.org/10.4049/jimmunol.180.2.1139
  24. Vila J, Saez-Lopez E, Johnson JR, Romling U, Dobrindt U, Canton R, et al. 2016. Escherichia coli: an old friend with new tidings. FEMS Microbiol. Rev. 40: 437-463. https://doi.org/10.1093/femsre/fuw005
  25. Mainil J. 2013. Escherichia coli virulence factors. Vet. Immunol. Immunopathol. 152: 2-12. https://doi.org/10.1016/j.vetimm.2012.09.032
  26. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. 2019. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathog. 11: 10. https://doi.org/10.1186/s13099-019-0290-0
  27. Bien J, Sokolova O, Bozko P. 2012. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int. J. Nephrol. 2012
  28. Kim KS. 2016. Human meningitis-associated Escherichia coli. EcoSal. Plus 7: 10.1128.
  29. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. 2001. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69: 5529-55237. https://doi.org/10.1128/IAI.69.9.5529-5537.2001
  30. Mokady D, Gophna U, Ron EZ. 2005. Virulence factors of septicemic Escherichia coli strains. Int. J. Med. Microbiol. 295: 455-462. https://doi.org/10.1016/j.ijmm.2005.07.007
  31. Sharma JN, Al-Omran A, Parvathy SS. 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15: 252-259. https://doi.org/10.1007/s10787-007-0013-x
  32. Lee E, Shin A, Kim Y 2015 Anti-inflammatory activities of cecropin A and its mechanism of action. Arch. Insect Biochem. Physiol. 87: 1-14 https://doi.org/10.1002/arch.21175
  33. Zhang JM, An J. 2007. Cytokines, inflammation, and pain. Int. Anesthesiol. Clin. 45: 27-37. https://doi.org/10.1097/AIA.0b013e318034194e
  34. Kim J, Jacob B, Jang M, Kwak C, Lee Y, Son K, et al. 2019 Development of a novel short 12-meric papiliocin-derived peptide that is effective against gram-negative sepsis. Sci. Rep. 9: 3817. https://doi.org/10.1038/s41598-019-40577-8
  35. Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151. https://doi.org/10.1016/j.cyto.2008.01.006

Cited by

  1. Metabolomics Insights of the Immunomodulatory Activities of Phlorizin and Phloretin on Human THP-1 Macrophages vol.26, pp.4, 2020, https://doi.org/10.3390/molecules26040787
  2. Flavonoid Phloretin Inhibits Adipogenesis and Increases OPG Expression in Adipocytes Derived from Human Bone-Marrow Mesenchymal Stromal-Cells vol.13, pp.11, 2021, https://doi.org/10.3390/nu13114185